- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.09. | Biogen expands portfolio in deal with Alcyone Therapeutics | ||
| 23.09. | New centre for life sciences launched in London | ||
| 22.09. | Osivax initiates phase 2b trial of influenza A vaccine candidate | ||
| 22.09. | Alistair Macdonald appointed as CEO of Worldwide Clinical Trials | ||
| 19.09. | Lilly to invest $5bn in US manufacturing facility | ||
| 19.09. | CMI Media Group opens a new office in Paris and announces Aurélie Rizzo as Director, Global | ||
| 18.09. | Roche to acquire 89bio in a deal worth up to US$3.5bn | ||
| 18.09. | James MacDonald appointed as CEO of Yellowstone Biosciences | ||
| 17.09. | VarmX and CSL to collaborate in research deal worth up to $2.1bn | ||
| 17.09. | Graphene Medical Animation launches | ||
| 16.09. | Amgen and Kyowa Kirin announce rocatinlimab results for atopic dermatitis | ||
| 16.09. | PMi Awards 2025 | ||
| 15.09. | Johnson & Johnson seeks first EMA approval for icotrokinra for plaque psoriasis | ||
| 12.09. | Lilly launches global Alzheimer's campaign with Julianne Moore | ||
| 12.09. | John Morikis joins Johnson & Johnson's board of directors | ||
| 11.09. | Novartis to acquire Tourmaline Bio in a deal worth $1.4bn | ||
| 11.09. | Resolution Therapeutics appoints Lucy Singah as CFO and Daniel Kennedy as CBO | ||
| 10.09. | Novo Nordisk to cuts 9,000 jobs in an effort to streamline its operations | ||
| 10.09. | Inizio appoints Ryan Quigley as new CEO | ||
| 09.09. | Lilly and Circle Pharma agree to collaborate on new oral macrocycle therapies | ||
| 09.09. | Emma Bush appointed as CNX Therapeutics' Vice President, Commercial | ||
| 08.09. | Invivyd working with FDA towards potential Biologics License Application for COVID-19 | ||
| 08.09. | Adam Raff appointed as Orbital Therapeutics' Senior Vice President, Clinical Development | ||
| 08.09. | Atlantic currents: the changing tide of health policy in the US and Europe | ||
| 05.09. | PhotoPharmics' new advisory board to guide launch of FDA Breakthrough device for Parkinson's |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .